Oxford BioDynamics PLC EXERCISE OF WARRANTS AND DIRECTOR DEALING (3583Y)
05 December 2017 - 6:01PM
UK Regulatory
TIDMOBD
RNS Number : 3583Y
Oxford BioDynamics PLC
05 December 2017
OXFORD BIODYNAMICS PLC
EXERCISE OF WARRANTS, DIRECTOR DEALING AND TOTAL VOTING
RIGHTS
London, 5 December 2017: Oxford BioDynamics Plc (AIM: OBD) (the
"Company") announces that it has received notice from Wentworth
Limited ("Wentworth") of the exercise of 689,441 warrants in
exchange for the issue of 689,441 ordinary shares of 1 pence each
("Ordinary Shares") (the "New Ordinary Shares"). The warrant
exercise was effected at the nominal price of 1 pence per Ordinary
Share and, in accordance with the terms of the warrant instrument,
Wentworth has simultaneously waived its subscription rights to the
balance of 1,032,523 warrant shares previously held.
Warrants over 1,721,964 Ordinary Shares were granted to
Wentworth on 30 November 2016 in consideration for Wentworth
procuring placees pursuant to the placing which took place on 6
December 2016, and general corporate and strategic advice. David
Williams, the Company's Chairman, is the beneficial owner of
Wentworth.
Following exercise of these warrants, through his beneficial
ownership of Wentworth, David Williams will be interested in a
total of 1,322,352 Ordinary Shares of 1 pence each in the Company,
representing approximately 1.52% of the Company's issued share.
Application will be made for the New Ordinary Shares, which rank
pari passu in all respects with the Company's existing Ordinary
Shares, to be admitted to trading on AIM which is expected to occur
on or around 12 December 2017.
Following issue of the New Ordinary Shares, the Company's total
issued share capital will consist of 86,787,669 Ordinary Shares
with one voting right per share. The Company does not hold any
Ordinary Shares in Treasury. Therefore, following the issue of the
New Ordinary Shares, the total number of voting rights in the
Company is 86,787,669. This figure may be used by shareholders as
the denominator for the calculations by which they will determine
if they are required to notify their interest in, or a change to
their interest in, the Company under the FCA's Disclosure Guidance
and Transparency Rules.
The notification below, made in accordance with the requirements
of the EU Market Abuse Regulation, provide further details:
1 Details of the person discharging managerial
responsibilities/person closely associated
--- ------------------------------------------------------------
a) Name David Williams
--- ------------------------ ----------------------------------
2 Reason for the notification
--- ------------------------------------------------------------
a) Position/status Non-Executive Chairman
--- ------------------------ ----------------------------------
b) Initial notification/ Initial notification
Amendment
--- ------------------------ ----------------------------------
3 Details of the issuer, emission allowance market
participant, auction platform, auctioneer or
auction monitor
--- ------------------------------------------------------------
a) Name Oxford BioDynamics Plc
--- ------------------------ ----------------------------------
b) LEI 2138005Y1TK258O5U928
--- ------------------------ ----------------------------------
4 Details of the transaction(s): section to be
repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and
(iv) each place where transactions have been
conducted
--- ------------------------------------------------------------
a) Description of Ordinary shares of 1 pence each
the financial
instrument, type ISIN: GB00BD5H8572
of instrument
Identification
code
--- ------------------------ ----------------------------------
b) Nature of the Exercise of warrants
transaction
--- ------------------------ ----------------------------------
c) Price(s) and 1 pence per ordinary share
volume(s)
689,441 ordinary shares
--- ------------------------ ----------------------------------
d) Aggregated information N/A
- Aggregated
volume
- Price
--- ------------------------ ----------------------------------
e) Date of the transaction 4 December 2017
--- ------------------------ ----------------------------------
f) Place of the London Stock Exchange, AIM (XLON)
transaction
--- ------------------------ ----------------------------------
For further details, contact:
Oxford BioDynamics
Plc +44 (0)1865 518910
Christian Hoyer Millar,
CEO
Paul Stockdale, CFO
Stifel Nicolaus Europe
Limited +44 (0)20 7710 7600
Nominated Advisor
and Broker
David Arch
Jonathan Senior
Peter Lees
Ben Maddison
Shore Capital +44 (0)20 7408 4090
Joint Broker
Edward Mansfield
FTI Consulting +44 (0)20 3727 1000
Financial Public Relations
Advisor
Julia Phillips
Brett Pollard
Natalie Garland-Collins
Notes for Editors
About Oxford BioDynamics Plc
Oxford BioDynamics Plc (AIM: OBD) ("Oxford BioDynamics") is a
revenue-generating biotechnology company focused on the discovery
and development of epigenetic biomarkers for use within the
pharmaceutical and biotechnology industry.
The Company's award-winning, proprietary technology platform,
EpiSwitch(TM), aims to accelerate the drug discovery and
development process, improve the success rate of therapeutic
product development and take advantage of the increasing importance
of personalised medicine.
In particular, EpiSwitch(TM) can reduce time to market, failure
rates and the costs at every stage of drug discovery. Additionally,
the technology provides significant insights into disease
mechanisms for drug discovery and product re--positioning
programmes, and enables the personalisation of therapeutics for
patients in the context of challenging pricing environments where
improved clinical outcomes are critical.
Oxford BioDynamics is headquartered in the UK, and listed on the
London Stock Exchange's AIM under the ticker "OBD". For more
information please visit www.oxfordbiodynamics.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDNEAEALEAXXFAF
(END) Dow Jones Newswires
December 05, 2017 02:01 ET (07:01 GMT)
Oxford Biodynamics (LSE:OBD)
Historical Stock Chart
From Apr 2024 to May 2024
Oxford Biodynamics (LSE:OBD)
Historical Stock Chart
From May 2023 to May 2024